INS and type 2 diabetes mellitus: Type-2 diabetes accounts for ∼90% of all diabetes cases [1] and it results from the metabolic disorders of insulin resistance (diminished sensitivity of the target tissues to insulin action) and β-cell failure (reduced ability of the pancreatic β-cells to produce sufficient insulin).